Miami University Researchers Collaborate with PsyBio Therapeutics to Biosynthetically Produce Psilocybin, the Psychedelic Ingredient in Magic Mushrooms, and Other Psychoactive Drug Candidates to Treat Mental Health Challenges
22 mai 2020 08h30 HE
|
PsyBio Therapeutics Inc.
OXFORD, Ohio, May 22, 2020 (GLOBE NEWSWIRE) -- via NetworkWire – Miami University in Oxford, Ohio, and PsyBio Therapeutics Inc. (“PsyBio”) www.psybiolife.com are collaborating to develop a new and...